The earnings call highlighted substantial progress in capital restructuring and cost reduction, positioning the company well for future growth. However, challenges remain with flat e-commerce sales, a decrease in overall net sales, and a working capital deficit.

Company Guidance -

Q3 2025

During the cbdMD, Inc. conference call discussing the second quarter of fiscal year 2025, significant financial and strategic progress was outlined. The conversion of Series A Preferred Stock into common stock eliminated approximately $6.7 million in accrued dividends and simplified the capital structure, while also raising the non-GAAP adjusted book value to over $7 million, surpassing the $4 million threshold required by the NYSE American. The company reported total net sales of $4.7 million, an 8.6% increase from the prior year, although a 7.9% decrease from the previous quarter. The wholesale business saw a 22% increase to $1.1 million, while e-commerce sales remained flat at $3.6 million, representing 77% of total net sales. Gross profit stood at 62%, with SG&A expenses reduced to $3.5 million, resulting in a net loss of $480,000 and a non-GAAP adjusted EBITDA loss of $197,000. Looking ahead, cbdMD plans to leverage its improved financial position for strategic growth initiatives, including potential M&A opportunities and expansion of its Herbal Oasis brand, with anticipated contributions to the top line in the latter half of the year.

Successful Series A Preferred Stock Conversion

The conversion of Series A Preferred Stock into common stock raised the company's pro forma non-GAAP adjusted book value from approximately $670,000 to over $7 million as of March 31, 2025.

Improved Financial Position

The company now has approximately 8.9 million shares of common stock outstanding with no debt, no warrant overhang, and a simplified capital structure, positioning it to regain compliance with NYSE American listing standards.

Wholesale Revenue Growth

Wholesale revenue increased by 22% to $1.1 million in the second quarter of fiscal 2025, compared to $750,000 in the same quarter of fiscal 2024.

Cost Reduction Achievements

SG&A expenses for the second quarter of fiscal 2025 were reduced to $3.5 million compared to $4.1 million in the prior year, due to reductions in payroll, professional fees, and the elimination of the headquarters lease.

Improved EBITDA

The company reported a non-GAAP adjusted EBITDA loss of $197,000 for the second quarter of fiscal 2025, compared to a $680,000 loss in the second quarter of fiscal 2024.

cbdMD (YCBD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

YCBD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 13, 2025	2025 (Q3)	-0.02 / -	-1.2	―	―	―
May 15, 2025	2025 (Q2)	-1.60 / -1.90	-10.8	82.41% (+8.90)	―
Feb 13, 2025	2025 (Q1)	- / -1.76	-5.36	67.16% (+3.60)	―	―
Dec 18, 2024	2024 (Q4)	-3.60 / 0.00	-46.96	―	―	―
Aug 14, 2024	2024 (Q3)	-4.96 / -1.20	-9.28	87.07% (+8.08)	―	―
May 15, 2024	2024 (Q2)	-6.00 / -10.80	-13.92	22.41% (+3.12)	―	―
Feb 13, 2024	2024 (Q1)	-5.92 / -5.36	-28.8	81.39% (+23.44)	―
Dec 22, 2023	2023 (Q4)	-6.08 / -46.96	-11.595	-305.00% (-35.37)	―
Aug 10, 2023	2023 (Q3)	- / -9.28	-24.758	62.52% (+15.48)	―
May 15, 2023	2023 (Q2)	- / -13.92	-34.542	59.70% (+20.62)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

YCBD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 15, 2025	$0.99	$0.95	-4.04%
Feb 13, 2025	$4.56	$3.87	-15.13%
Dec 18, 2024	$3.18	$2.96	-6.92%
Aug 14, 2024	$3.88	$3.94	+1.55%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does cbdMD (YCBD) report earnings?

cbdMD (YCBD) is schdueled to report earning on Aug 13, 2025, Before Open (Confirmed).

What is cbdMD (YCBD) earnings time?

cbdMD (YCBD) earnings time is at Aug 13, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is YCBD EPS forecast?

YCBD EPS forecast for the fiscal quarter 2025 (Q3) is -0.02.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing